These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19603419)

  • 41. BDNF val66met polymorphism is associated with age at onset and intensity of symptoms of paranoid schizophrenia in a Polish population.
    Suchanek R; Owczarek A; Paul-Samojedny M; Kowalczyk M; Kucia K; Kowalski J
    J Neuropsychiatry Clin Neurosci; 2013; 25(1):88-94. PubMed ID: 23487199
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between BDNF gene polymorphisms and attention deficit hyperactivity disorder in Korean children.
    Kwon HJ; Ha M; Jin HJ; Hyun JK; Shim SH; Paik KC; Park WS; Lim MH
    Genet Test Mol Biomarkers; 2015 Jul; 19(7):366-71. PubMed ID: 25950609
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of BDNF val66met polymorphism on the association between physical activity and incident dementia.
    Kim JM; Stewart R; Bae KY; Kim SW; Yang SJ; Park KH; Shin IS; Yoon JS
    Neurobiol Aging; 2011 Mar; 32(3):551.e5-12. PubMed ID: 20172629
    [TBL] [Abstract][Full Text] [Related]  

  • 44. BDNF Val66Met polymorphism and anxiety/depression symptoms in schizophrenia in a Chinese Han population.
    Sun MM; Yang LM; Wang Y; Feng X; Cui KY; Liu LF; Chen ZY
    Psychiatr Genet; 2013 Jun; 23(3):124-9. PubMed ID: 23532065
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Val66Met polymorphism and serum brain-derived neurotrophic factor in bipolar disorder: an open-label trial.
    Grande I; Magalhães PV; Chendo I; Stertz L; Fries GR; Cereser KM; Cunha ÂB; Gói P; Kunz M; Udina M; Martín-Santos R; Frey BN; Vieta E; Kapczinski F
    Acta Psychiatr Scand; 2014 May; 129(5):393-400. PubMed ID: 23957567
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Brain-derived neurotrophic factor gene C-270T and Val66Met functional polymorphisms and risk of schizophrenia: a moderate-scale population-based study and meta-analysis.
    Xu MQ; St Clair D; Ott J; Feng GY; He L
    Schizophr Res; 2007 Mar; 91(1-3):6-13. PubMed ID: 17289348
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of brain-derived neurotrophic factor (val66met) genetic polymorphism on the ages of onset for heroin abuse in males.
    Hou H; Qing Z; Jia S; Zhang X; Hu S; Hu J
    Brain Res; 2010 Sep; 1353():245-8. PubMed ID: 20655300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Correlation between single nucleotide polymorphisms of neurotrophic factors and executive function characteristics in children with attention deficit hyperactivity disorder].
    Wang N; Wang Z; Yan F; Fu W
    Wei Sheng Yan Jiu; 2019 Jul; 48(4):577-582. PubMed ID: 31601338
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sexually dimorphic effect of the Val66Met polymorphism of BDNF on susceptibility to Alzheimer's disease: New data and meta-analysis.
    Fukumoto N; Fujii T; Combarros O; Kamboh MI; Tsai SJ; Matsushita S; Nacmias B; Comings DE; Arboleda H; Ingelsson M; Hyman BT; Akatsu H; Grupe A; Nishimura AL; Zatz M; Mattila KM; Rinne J; Goto Y; Asada T; Nakamura S; Kunugi H
    Am J Med Genet B Neuropsychiatr Genet; 2010 Jan; 153B(1):235-42. PubMed ID: 19504537
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Family-based and case-control association studies of catechol-O-methyltransferase in attention deficit hyperactivity disorder suggest genetic sexual dimorphism.
    Qian Q; Wang Y; Zhou R; Li J; Wang B; Glatt S; Faraone SV
    Am J Med Genet B Neuropsychiatr Genet; 2003 Apr; 118B(1):103-9. PubMed ID: 12627475
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Study on the possible association of brain-derived neurotrophic factor polymorphism with the developmental course of symptoms of attention deficit and hyperactivity.
    Bergman O; Westberg L; Lichtenstein P; Eriksson E; Larsson H
    Int J Neuropsychopharmacol; 2011 Nov; 14(10):1367-76. PubMed ID: 21466746
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The brain-derived neurotrophic factor Val66Met polymorphism is associated with reduced hippocampus perfusion in frontotemporal lobar degeneration.
    Borroni B; Bianchi M; Premi E; Alberici A; Archetti S; Paghera B; Cerini C; Papetti A; Padovani A
    J Alzheimers Dis; 2012; 31(2):243-51. PubMed ID: 22596272
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increase in serum brain-derived neurotrophic factor in met allele carriers of the BDNF Val66Met polymorphism is specific to males.
    Bus BA; Arias-Vasquez A; Franke B; Prickaerts J; de Graaf J; Voshaar RC
    Neuropsychobiology; 2012 Jun; 65(4):183-7. PubMed ID: 22538247
    [TBL] [Abstract][Full Text] [Related]  

  • 54. BDNF-Dependent Effects on Amygdala-Cortical Circuitry and Depression Risk in Children and Youth.
    Wheeler AL; Felsky D; Viviano JD; Stojanovski S; Ameis SH; Szatmari P; Lerch JP; Chakravarty MM; Voineskos AN
    Cereb Cortex; 2018 May; 28(5):1760-1770. PubMed ID: 28387866
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior.
    Hong CJ; Huo SJ; Yen FC; Tung CL; Pan GM; Tsai SJ
    Neuropsychobiology; 2003; 48(4):186-9. PubMed ID: 14673216
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression.
    Hwang JP; Tsai SJ; Hong CJ; Yang CH; Lirng JF; Yang YM
    Neurobiol Aging; 2006 Dec; 27(12):1834-7. PubMed ID: 16343697
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fine-mapping of the brain-derived neurotrophic factor (BDNF) gene supports an association of the Val66Met polymorphism with episodic memory.
    Cathomas F; Vogler C; Euler-Sigmund JC; de Quervain DJ; Papassotiropoulos A
    Int J Neuropsychopharmacol; 2010 Sep; 13(8):975-80. PubMed ID: 20482942
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in Parkinson's disease and age of onset.
    Hong CJ; Liu HC; Liu TY; Lin CH; Cheng CY; Tsai SJ
    Neurosci Lett; 2003 Dec; 353(1):75-7. PubMed ID: 14642442
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of single nucleotide polymorphisms in the miR-183-96-182 cluster in adulthood attention-deficit and hyperactivity disorder (ADHD) and substance use disorders (SUDs).
    Sánchez-Mora C; Ramos-Quiroga JA; Garcia-Martínez I; Fernàndez-Castillo N; Bosch R; Richarte V; Palomar G; Nogueira M; Corrales M; Daigre C; Martínez-Luna N; Grau-Lopez L; Toma C; Cormand B; Roncero C; Casas M; Ribasés M
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1463-73. PubMed ID: 23906647
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased Risk-Taking Behaviour and Brain-Derived Neurotrophic Factor Val66Met Polymorphism Correlates to Decreased Serum Brain-Derived Neurotrophic Factor Level in Heroin Users.
    Roviš D; Černelič Bizjak M; Vasiljev Marchesi V; Petelin A; Jenuš T; Vidic S; Drevenšek G; Jenko Pražnikar Z
    Eur Addict Res; 2018; 24(4):189-200. PubMed ID: 30134233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.